Abstract This report presents an analysis of four patients who suffered from longstanding untreated hypothyroidism, with special attention to the phase of catch-up growth after the start of L-thyroxine treatment. Although a permanent height loss could not be prevented, the capacity to establish a remarkable catch-up growth spurt proved to be still intact, even after a long period of thyroid dysfunction.
Abbreviation FTI free thyroxine index introduction At delivery children with congenital hypothyroidism have a length similar to that of healthy children, but without replacement therapy with L-thyroxine (L-T4) their growth rate diminishes shortly afterwards [2, 4, 7] . A continuing decrease or even complete arrest of statural growth is observed if congenital or acquired juvenile hypothyroidism remains untreated. It has been suggested that adequate treatment of hypothyroidism leads to complete catch-up growth and a normal adult stature [4, 12, 16] . It is now clear that short stature can indeed be prevented if L-T 4 substitution is started at an early age [1, 3] , but if hypothyroidism remains untreated for a longer period a permanent height loss cannot always be avoided [2, 11, 13] . However, the number of reported clinicai observations on long-term growth after prolonged untreated hypothyroidism is still relatively small [2, 4, 11, 13] and most of these studies did not involve the parental heights and the pre-illness growth curve in the estimation of the loss in adult height.
We present a description of four patients in whom hypothyroidism was left untreated for long period and discuss its consequences for catch-up growth.
Patients

Patient 1
A girl of Indonesian origin developed feeding difficulties shortly after birth requiring hospitalisation. Congenital hypothyroidism was diagnosed and L-T4 replacement therapy was started. Therapy was discontinued after 4 months as a result of parental ignorance and the patient was lost to follow up. Finally, at the age of 13.9 years, she visited our clinic because she had become extremely slow. Physical examination showed a prepubertal, clearly apathetic, mentally retarded girl unable to speak and walk, with a height of 81 cm (3rd percentile = 151.2 cm) and a weight of 13.4 kg (3rd percentile = 37.3 kg). Her face showed coarse, puffy features with large lips and a big tongue, a flat nose and myxoedema (Fig. la) . She had brittle hair and a pale skin. The abdomen was distended and an umbilical hernia was present, while her arms showed slight contractures and her legs were strongly bowed. Her psychomotor development was equal to that of a child at the age of 13 months. Additional investigations showed a serum total T4 < 13 nmol/1, free thyroxine index (FTI) < 13, TSH > 60 mU/1 and cholesterol 11.0 mmol/1. X-ray investigations revealed stippled epiphyses of the femoral heads, immature vertebrae and bowed tibiae. L-T4 substitution therapy was resumed and followed by a remarkable improvement of clinical symptoms (Fig. lb) . The first manifestations of pubertal development were noted within 8 months.
Patient 2
A 14-year-old boy was referred because of growth failure. At the age of 13 years he had undergone a surgical correction for epiphysiolysis of both femoral heads. Physical examination showed a boy with a pale, puffy face and skin depigmentation. Tanner stages were A1P1G1 but the testicular volume was 12 ml. His IQ was normal. Additional investigations showed a total T 4 of 10 nmol/1, free T 4 0.8 pmol/1 and TSH 367 mU/1. Microsomal antibodies were positive and thyroglobulin antibodies negative. Plasma testosterone was 1.3 nmol/1. Cortisol secretion was normal. He was diagnosed as having primary hypothyroidism, probably due to Hashimoto thyroiditis and L-T4 substitution therapy was started. Shortly thereafter a progression of genital development was noted and within 10 months he had reached genital stage 4.
Patient 3
A 13-year-old girl was referred because of growth failure and increased body weight. She also reported increased hair growth and a lowered voice. Physical examination showed an apathetic and slightly obese girl with a pale coloured skin and a heart rate of 44 beats/min. She had hypertrichosis on the back, arms and legs, but no further signs of virilisation could be detected. Her psychological development was normal. Tanner stages were B3P3 and menarche had not occurred. Additional investigations showed a total T4 of 5 nmol/1, FTI < 2 and TSH 580 mUll and cholesterol 13.7 mmol/1. The presence of anticolloidal antibodies was dubious and antinuclear antibodies were weakly positive. The levels of circulating androgens were normal. Primary hypothyroidism was diagnosed, probably due to Hashimoto thyroiditis, and L-T4 substitution therapy was started. The hypertrichosis was of familiar origin. Pubertal development progressed and menarche occurred at the age of 14.5 years.
Patient 4
A nearly 6-year-old girl was referred because of abdominal pain, anorexia and fatigue. Physical examination showed a short, prepubertal girl with a puffy, broad and round face, macroglossia and a pale skin. Her psychological development was normal. Additional investigations: total T 4 22 nmol/1, FTI 19, TSH 60 mU/1, thyroglobulin antibodies and microsomal antibodies were absent. Xray investigations revealed stippled epiphyses of the femoral heads. On scintigraphy no thyroid gland could be visualised, but ectopic thyroid tissue was detected at the base of the tongue, which was consistent with the findings of indirect laryngoscopy. Therefore she was diagnosed as having primary hypothyroidism probably resulting from decompensation of an ectopic dysgenetic thyroid gland and L-T4 substitution therapy was started. Pubertal development started at the age of 10.7 years and menarche occurred at the age of 13.6 years. 
Results
In these patients the duration of hypothyroidism before onset of therapy, as measured by the duration of growth deceleration, varied from 5 to 13.5 years (Table 1 ). This period of untreated hypothyroidism had led to an extreme (patient 1) or marked (patients 2-4) growth retardation ( Fig. 2 a-d) . After the institution of L-T4 treatment all patients exhibited a marked catch-up growth spurt, which is not distinguishable from the pubertal growth spurt in patients 1-3. This growth spurt enabled the patients to achieve an increase of height SDS for chronological age varying from 2.7 to 8. 
Discussion
All four patients show the impressive growth retarding influence of a prolonged period of untreated hypothyroidism. As neonatal screening procedures, routine measurements at child welfare centres and examinations by school doctors usually lead to early detection of hypothyroidism in children, these observations are nowadays relatively uncommon in western countries. The marked acceleration of growth that occurred in all patients after the start of L-T4 therapy shows that the capacity to establish a considerable catch-up growth spurt remains intact even after a long period of hypothyroidism, Although the catch-up spurt corrected an important part of the initial height deficit in all patients, three of them did not reach their target height and the adult height of the fourth patient was presumably also reduced.
Three possible explanations for this failure to reach complete catch-up growth after a longlasting period of hy- pothyroidism have been proposed [13] . Firstly, hypothyroidism may directly diminish the potential for catch-up growth. Secondly, overtreatment with L-T 4 may stimulate skeletal maturation too much and finally, pubertal development during the catch-up phase may limit the chance to achieve full catch-up growth.
The way in which hypothyroidism may diminish the potential for catch-up growth has not been described but the most likely mechanism seems through irreversible damage to the cartilage growth plates. The influence of hypothyroidism on osseous development is well known [18] and illustrated by the signs of epiphyseal dysgenesis in patients 1 and 4 and by the history of epiphysiolysis in patient 2. However, although it has been reported that hypothyroidism indeed causes damage to the epiphyseal growth plate cartilage, this proved to be fully reversible during L-T 4 treatment [8] . Therefore it is questionable whether this explains incomplete catch-up growth in our patients.
Although thyroid hormones are indeed important stimulators of skeletal maturation, it is also unlikely that overtreatment with L-T4 has caused incomplete catch-up growth in these patients. They all received the recommended daily dosage of 100 ~tg/m 2 L-Y 4 and none of them showed clinical or biochemical evidence of excess of thyroid hormones.
The third explanation seems to correspond best with the observations in our patients. Patient 1 entered puberty shortly after the start of treatment and failed to reach her target height. Patients 2 and 3 already showed signs of pubertal development at the start of treatment and failed to return to the pre-illness percentile position or to reach target height. Patient 4 entered into puberty more than 4 years after the start of treatment and she was the only patient who reached nearly complete catch-up growth. These observations seem to confirm that if L-T4 substitution is initiated at the moment that the patient has already entered puberty or if pubertal onset occurs shortly thereafter, catch-up growth is incomplete. Sex steroids probably induce a disproportional acceleration of bone maturation in relation to linear growth, which finally results in epiphyseal fusion before complete catch-up growth has been reached.
A recent case report showed that suppression of pubertal development by administration of synthetic gonadotropin releasing hormone plus growth hormone improved height gain in a patient with juvenile hypothyroidism [9] . This approach of gonadal suppression in combination with growth hormone therapy in order to improve final height is sometimes also applied in conditions such as idiopathic short stature [6, 14] , idiopathic growth hormone deficiency [5, 17] and precocious puberty [10, 15] . It is tempting to speculate that the outcome of catch-up growth in the first three of the herein described patients might have been better if they had been treated according to this new therapeutic strategy.
In summary, hypothyroidism exerts profound effects on human growth. Nevertheless, even after an extremely long period of thyroid dysfunction the capacity to establish a striking catch-up growth spurt remains intact. However, catch-up may be incomplete in patients in whom therapy is started shortly before or during puberty.
